Thank you to Brad Loncar with BiotechTV for stopping by our new headquarters to speak with our CEO, Lisa Deschamps! Learn more about our direct delivery approach and our investigational gene therapies in development for #FrontotemporalDementia (#FTD) and #ALS below. #GeneTherapy #Biotech
𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: Canary Wharf based AviadoBio entered the clinic in April with the world's first-in-human intrathalamic delivered gene therapy for a type of dementia. CEO Lisa Deschamps describes this now clinical program for frontotemporal dementia, and Aviado's broader platform for using gene therapies and silencers against neurodegenerative diseases. Full video: https://lnkd.in/gjsUhCkq BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
Chief Scientific Advisor, Head-Global Medical Engagement
2moCongratulations Lisa! Great job.